Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2020
∙
Vygen-Bonnet, S. Hellenbrand, W. Garbe, E. von Kries, R. Bogdan, C. Heininger, U. Robl-Mathieu, M. Harder, T.
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review
2020
∙
Mangtani, P. Evans, S. J. W. Lange, B. Oberle, D. Smith, J. Drechsel-Baeuerle, U. Keller-Stanislawski, B.
Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant
2020
∙
Bache, B. E. Grobusch, M. P. Agnandji, S. T.
Safety, immunogenicity and risk-benefit analysis of rVSV-DELTAG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions
2020
∙
Okoli, G. N. Lam, O. L. T. Racovitan, F. Reddy, V. K. Righolt, C. H. Neilson, C. Chit, A. Thommes, E. Abou-Setta, A. M. Mahmud, S. M.
Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors
2020
∙
Alizadeh Chamkhaleh, M. Esteghamati, A. Sayyahfar, S. Gandomi-Mohammadabadi, A. Balasi, J. Abdiaei, H. Moradi, Y. Moradi-Lakeh, M.
Serotype distribution of Streptococcus pneumoniae among healthy carriers and clinical patients: a systematic review from Iran
2020
∙
Kuehne, F. Sanftenberg, L. Dreischulte, T. Gensichen, J.
Shared decision making enhances pneumococcal vaccination rates in adult patients in outpatient care
2020
∙
Palencia-Sánchez, F. Echeverry-Coral, S. J.
Social considerations affecting acceptance of HPV vaccination in Colombia. A systematic review
2020
∙
Riccò, M. Gualerzi, G. Ranzieri, S. Bragazzi, N. L.
Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now)
2020
∙
Villa, A. Patton, L. L. Giuliano, A. R. Estrich, C. G. Pahlke, S. C. O'Brien, K. K. Lipman, R. D. Araujo, M. W. B.
Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews
2020
∙
Tin Tin Htar, M. Jackson, S. Balmer, P. Serra, L. C. Vyse, A. Slack, M. Riera-Montes, M. Swerdlow, D. L. Findlow, J.
Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register